Cost analysis of rapid diagnostics for drug-resistant tuberculosis

Erik Groessl, Theodore Ganiats, Naomi Hillery, Andre Trollip, Roberta Jackson, Donald Catanzaro, Timothy Rodwell, Richard Garfein, Camilla Rodrigues, Valeriu Crudu, Thomas Victor & Antonino Catanzaro
Abstract Background Growth-based drug susceptibility testing (DST) is the reference standard for diagnosing drug-resistant tuberculosis (TB), but standard time to result (TTR) is typically ≥ 3 weeks. Rapid tests can reduce that TTR to days or hours, but accuracy may be lowered. In addition to the TTR and test accuracy, the cost of a diagnostic test may affect whether it is adopted in clinical settings. We examine the cost-effectiveness of rapid diagnostics for extremely drug-resistant TB...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.